ALBERT DAVID LTD. (ALBERTDAVD.BO)
- Previous Close
872.70 - Open
873.95 - Bid 875.60 x --
- Ask 885.00 x --
- Day's Range
870.70 - 890.90 - 52 Week Range
763.90 - 1,752.95 - Volume
838 - Avg. Volume
1,151 - Market Cap (intraday)
5.022B - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
12.42 - EPS (TTM)
70.86 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 11.50 (1.32%)
- Ex-Dividend Date Aug 2, 2024
- 1y Target Est
--
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
www.albertdavidindia.com1,497
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ALBERTDAVD.BO
View MorePerformance Overview: ALBERTDAVD.BO
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALBERTDAVD.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALBERTDAVD.BO
View MoreValuation Measures
Market Cap
4.98B
Enterprise Value
1.79B
Trailing P/E
12.31
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.39
Price/Book (mrq)
1.21
Enterprise Value/Revenue
0.50
Enterprise Value/EBITDA
2.88
Financial Highlights
Profitability and Income Statement
Profit Margin
11.24%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.6B
Net Income Avi to Common (ttm)
404.41M
Diluted EPS (ttm)
70.86
Balance Sheet and Cash Flow
Total Cash (mrq)
3.17B
Total Debt/Equity (mrq)
0.85%
Levered Free Cash Flow (ttm)
--